Persistent loss of thermoregulation in the rat induced by 3,4-methylenedioxymethamphetamine (MDMA or "Ecstasy") but not by fenfluramine

Psychopharmacology (Berl). 1998 Jul;138(2):207-12. doi: 10.1007/s002130050664.

Abstract

Using radio-biotelemetry, the timecourse of recovery and sensitivity to ambient temperature (Ta) of the thermogenic response of methylenedioxymethamphetamine (MDMA or "Ecstasy") was examined. Ambient temperatures of 17 and 22 degrees C produced very different response profiles, with the lower temperature producing a hypothermic response to 10 and 15 mg/kg doses of MDMA, and the higher temperature producing a profound hyperthermia to the same doses. Although the peak responses to the drug had subsided within 5 h of administration, residual effects, in the form of an elevation of body temperature during the "low" phase of the diurnal cycle, were present for a further 48 h. Long-lasting disruption of the thermoregulatory system following a short series of MDMA administrations (10 mg/kg once per day for 4 days) was shown by exposing the rats in the undrugged state to a thermoregulatory challenge, consisting of 60-min exposure to a Ta of 30 degrees C, at 1 week before, and at 4 weeks and 14 weeks after the drug administration. MDMA-treated rats showed a prolonged hyperthermic response to the challenge at both post-drug intervals compared with fenfluramine-treated rats and saline-treated controls. Thus, the results indicate both that MDMA's thermogenic effects are more sensitive to Ta than previously demonstrated, and that the serotonergic neurotoxicity of the drug may produce long-lasting changes in thermoregulatory mechanisms.

MeSH terms

  • Amphetamine / pharmacology
  • Animals
  • Body Temperature Regulation / drug effects*
  • Dopamine Agents / pharmacology
  • Female
  • Fenfluramine / pharmacology*
  • N-Methyl-3,4-methylenedioxyamphetamine / pharmacology*
  • Rats
  • Rats, Wistar
  • Serotonin Agents / pharmacology*

Substances

  • Dopamine Agents
  • Serotonin Agents
  • Fenfluramine
  • Amphetamine
  • N-Methyl-3,4-methylenedioxyamphetamine